The Disco App, born from “DIScussions of COst” and designed by Dr Hamel and her team, is a novel point-of-care communication intervention aimed at improving discussions of cost between patients and their oncologists, while alleviating financial toxicity in the process.
FDA-approved oral cancer drugs are not cheap, and many patients are unable to afford these promising therapies with extremely high price tags. Depending on the type of cancer and the drug used to treat it, the price of oral cancer therapy can range from about $10,000 to $25,000 per month.
Availability and Accessibility of Cancer Care Delivery Approaches to Reduce Financial Toxicity of Rural and Urban Cancer Patients in Kentucky
A study of healthcare staff perspectives of financial toxicity experienced by cancer patients and staff- and systems-level cancer care delivery approaches for addressing financial toxicity.
Joanna Fawzy Morales, Esq., and Monica Fawzy Morales, Esq. share advice on how patients with cancer can avoid financial toxicity, as well as resources for those experiencing it.
The higher the financial distress experienced by a patient with cancer, the lower their health-related quality of life.
- Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
- Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda in Advanced Head and Neck Cancers
- Discussing Costs of Genomic Testing with Patients
A commentary on the government’s efforts to reduce the price of drugs for patients who have cancer or other chronic illnesses.
This educational initiative, derived from the 2017 AONN+ West Coast Regional Meeting, is designed to meet the educational needs of hematology/oncology nurse navigators and registered nurses; other healthcare professionals, such as patient navigators and social workers who have a focus on cancer and survivorship, are encouraged to participate.
With a growing underinsured patient population and rising costs of care, the need to prepare patients for financial burdens is crucial. This webinar, which is part of a collaboration between Cordata Healthcare Innovations and The NaVectis Group, will introduce you to the latest trends, effective practices, and strategies to better position your program to support patients as they deal with the financial issues surrounding complex disease diagnosis and treatment.
At the recent 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer, Ronan Kelly, MD, Johns Hopkins Medicine International, The Sidney Kimmel Cancer Center, Baltimore, MD, spoke about financial toxicity, the need for value-based care to address it, and what oncologists and healthcare providers can do to reduce costs of cancer care.
Page 1 of 2
Results 1 - 10 of 14
Results 1 - 10 of 14